Errors occurred in the abstract of this paper by Shin and colleagues (BMJ 2024;386:e079475, doi:10.1136/bmj-2024-079475, published 28 August 2024). In the final sentence of the results section, the text should have stated: The association was greater for more than two years of treatment (hazard ratio for [not of] dementia 0.52, 95% CI 0.41 to 0.66 [not 0.57, 0.46 to 0.70] than for two years or less (0.57, 0.46 to 0.70 [not 0.52, 0.41 to 0.66] and persisted across subgroups.
. 2024 Sep 2;386:q1911. doi: 10.1136/bmj.q1911
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study
Collection date 2024.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
PMCID: PMC11367712 PMID: 39222978